Basal Ganglia Pathophysiology
1 – 10 of 138
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia
- 2017
- Translating scientific advances into disease-modifying therapies for Parkinson's Disease
- Molecular Mechanisms of L-DOPA-Induced Dyskinesia
- Modeling Parkinson's disease and treatment complications in rodents : Potentials and pitfalls of the current options
- Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease
- Animal models of l-DOPA-induced dyskinesia : the 6-OHDA-lesioned rat and mouse
- CK2 oppositely modulates L-DOPA-induced dyskinesia via striatal projection neurons expressing D1 or D2 receptors
- Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia
- Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease
- Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease